AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Secured Loans History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Secured Loans | ₹798 Cr | ₹1,159 Cr | ₹2,135 Cr | ₹619 Cr | ₹249 Cr |
What is the latest Secured Loans ratio of AUROBINDO PHARMA ?
| Year | Secured Loans |
|---|---|
| Mar2026 | ₹798 Cr |
| Mar2025 | ₹1,159 Cr |
| Mar2024 | ₹2,135 Cr |
| Mar2023 | ₹619 Cr |
| Mar2022 | ₹249 Cr |
How is Secured Loans of AUROBINDO PHARMA Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2026 | ₹798 Cr | -31.15 | |
| Mar2025 | ₹1,159 Cr | -45.69 | |
| Mar2024 | ₹2,135 Cr | 244.92 | |
| Mar2023 | ₹619 Cr | 148.37 | |
| Mar2022 | ₹249 Cr | - | |
Compare Secured Loans of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹95,228.7 Cr | 5.5% | -2.7% | 49.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 5.5% |
-2.7% |
49.2% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses